Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-12 5:33 pm Sale | 2025-06-10 | 13D | Vigil Neuroscience, Inc. VIGL | Vida Ventures GP III, L.L.C. | 1,634,798 3.500% | -1,207,202 (-42.48%) | Filing History |
| 2025-06-09 5:48 pm Sale | 2025-06-05 | 13D | Vigil Neuroscience, Inc. VIGL | Vida Ventures GP III, L.L.C. | 2,842,000 6.100% | -2,200,012 (-43.63%) | Filing History |
| 2025-06-04 5:24 pm Purchase | 2025-05-28 | 13G | Vigil Neuroscience, Inc. VIGL | Glazer Capital, LLC | 2,513,462 5.390% | 2,513,462 (New Position) | Filing History |
| 2025-05-30 5:04 pm Purchase | 2025-05-22 | 13G | Vigil Neuroscience, Inc. VIGL | Beryl Capital Management LLC | 4,606,267 9.900% | 4,606,267 (New Position) | Filing History |
| 2025-05-27 6:26 pm Sale | 2025-05-22 | 13D | Vigil Neuroscience, Inc. VIGL | Northpond Ventures, LP | 0 0.000% | -4,214,498 (Position Closed) | Filing History |
| 2025-05-15 4:42 pm Purchase | 2025-03-31 | 13G | Vigil Neuroscience, Inc. VIGL | BIOTECHNOLOGY VALUE FUND L P | 4,734,500 9.990% | 1,994,773 (+72.81%) | Filing History |
| 2025-02-12 4:30 pm Unchanged | 2024-12-31 | 13G | Vigil Neuroscience, Inc. VIGL | Invus Public Equities, L.P. | 1,991,038 4.900% | 0 (Unchanged) | Filing History |
| 2024-11-14 4:19 pm Sale | 2024-09-30 | 13G | Vigil Neuroscience, Inc. VIGL | Citadel Advisors LLC | 1,442,489 3.600% | -719,413 (-33.28%) | Filing History |
| 2024-11-14 10:00 am Sale | 2024-09-30 | 13G | Vigil Neuroscience, Inc. VIGL | Deep Track Capital, LP | 1,553,996 3.920% | -2,095,730 (-57.42%) | Filing History |
| 2024-10-09 6:22 pm Purchase | 2024-08-13 | 13D | Vigil Neuroscience, Inc. VIGL | Vida Ventures GP III, L.L.C. | 5,042,012 12.700% | 26,083 (+0.52%) | Filing History |
| 2024-08-12 5:02 pm Purchase | 2024-08-01 | 13G | Vigil Neuroscience, Inc. VIGL | Invus Public Equities, L.P. | 1,991,038 5.300% | 1,991,038 (New Position) | Filing History |
| 2024-03-29 4:30 pm Unchanged | 2024-03-29 | 13G | Vigil Neuroscience, Inc. VIGL | Artal Participations S.a r.l | 1,811,191 4.900% | 0 (Unchanged) | Filing History |
| 2024-02-14 4:57 pm Sale | 2023-12-31 | 13G | Vigil Neuroscience, Inc. VIGL | Citadel Advisors LLC | 2,161,902 6.000% | -2,014 (-0.09%) | Filing History |
| 2024-02-14 11:33 am Sale | 2023-12-31 | 13G | Vigil Neuroscience, Inc. VIGL | Deep Track Capital, LP | 3,649,726 9.620% | -34,893 (-0.95%) | Filing History |
| 2024-02-12 5:31 pm Sale | 2023-12-31 | 13G | Vigil Neuroscience, Inc. VIGL | Deerfield Mgmt, L.P. | 1,173,523 3.270% | -878,487 (-42.81%) | Filing History |
| 2024-02-09 5:13 pm Sale | 2023-12-31 | 13G | Vigil Neuroscience, Inc. VIGL | Artal Participations S.a r.l | 1,811,191 5.000% | -432,161 (-19.26%) | Filing History |
| 2023-02-14 4:10 pm Purchase | 2022-12-31 | 13G | Vigil Neuroscience, Inc. VIGL | Hatteras Venture Partners VI LP | 1,565,578 4.400% | 1,565,578 (New Position) | Filing History |
| 2023-02-14 08:02 am Purchase | 2022-12-31 | 13G | Vigil Neuroscience, Inc. VIGL | Citadel Advisors LLC | 2,163,916 6.100% | 55,196 (+2.62%) | Filing History |
| 2023-02-10 7:36 pm Sale | 2022-12-31 | 13G | Vigil Neuroscience, Inc. VIGL | Artal Participations S.a r.l | 2,243,352 6.300% | -42,222 (-1.85%) | Filing History |
| 2023-02-10 4:31 pm Purchase | 2022-01-11 | 13D | Vigil Neuroscience, Inc. VIGL | Vida Ventures GP III, L.L.C. | 5,015,929 14.100% | 5,015,929 (New Position) | Filing History |